Reverse engineering a predictive signature characterized by proliferation, DNA damage, and immune escape from stage I lung adenocarcinoma recurrence
J Yao, X Xue, D Qu, CB Westphalen… - Acta biochimica et …, 2020 - academic.oup.com
Identifying early-stage cancer patients at risk for progression is a major goal of biomarker
research. This report describes a novel 19-gene signature (19-GCS) that predicts stage I …
research. This report describes a novel 19-gene signature (19-GCS) that predicts stage I …
[PDF][PDF] Formulation Development, Pharmacokinetic and Pharmacodynamic Assessments of a Combination regimen of Paclitaxel and Calcipotriol in a KrasG12D …
VR Lincha - 2021 - uh-ir.tdl.org
Pancreatic ductal adenocarcinoma (PDAC) is a human health challenge whose solution
remains elusive. Advancement in our understanding of PDAC has uncovered significant …
remains elusive. Advancement in our understanding of PDAC has uncovered significant …
Diagnostik und Therapie des Pankreaskarzinoms
Das Pankreaskarzinom weist eine weltweit steigende Inzidenz auf, wobei die Gründe hierfür
bis dato nicht bekannt sind. Die NCCN-Leitlinie von 2017 empfiehlt zur Diagnose und …
bis dato nicht bekannt sind. Die NCCN-Leitlinie von 2017 empfiehlt zur Diagnose und …
Clinical effect of nanoparticle albumin-bound paclitaxel combined with gemcitabine in treatment of advanced pancreatic cancer: a meta-analysis
W Yun, Z GengYuan, L ZhangJiang, Y HanTeng - 临床肝胆病杂志, 2019 - lcgdbzz.org
Objective To investigate the clinical effect of nanoparticle albumin-bound paclitaxel (nab-
paclitaxel) combined with gemcitabine in the treatment of advanced pancreatic cancer, and …
paclitaxel) combined with gemcitabine in the treatment of advanced pancreatic cancer, and …
ASO Author Reflections: Irreversible Electroporation for Locally Advanced Pancreatic Cancer
Although current chemotherapeutic regimens, including gemcitabine/nab-paclitaxel and
FOLFIRINOX, have increased the resectability rates of locally advanced pancreatic cancer …
FOLFIRINOX, have increased the resectability rates of locally advanced pancreatic cancer …
The Role of Natural Killer Cells in Gut Microbiota Mediated Pancreatic Cancer Progression
Q Yu - 2021 - search.proquest.com
Pancreatic cancer is the third leading cause of cancer-related death in the United States with
the lowest survival rate among all the solid cancer types. The gut microbiota, composed of …
the lowest survival rate among all the solid cancer types. The gut microbiota, composed of …
[引用][C] Karnosik asit ve gallik asitin PANC-1 pankreas hücrelerinde HNF1A geni üzerine sitotoksik etkilerinin karşılaştırmalı olarak incelenmesi
ED Ünal - 2021 - Kocaeli Üniversitesi, Fen Bilimleri …
Pancreatic Disorders 23
KK Das - The Washington Manual Gastroenterology …, 2020 - books.google.com
The pancreas is a mixed endocrine and exocrine gland consisting of lobular subunits
composed of acini. 1, 2 The exocrine pancreas consists of acinar, centroacinar, and ductal …
composed of acini. 1, 2 The exocrine pancreas consists of acinar, centroacinar, and ductal …
[HTML][HTML] Neoadjuvant double metal stent placement in a patient with locally unresectable cancer of the panceatic head—a case report
H Wittenburg, T Kirchner… - Digestive Medicine …, 2021 - dmr.amegroups.org
Pancreatic cancer still has a poor prognosis and the only curative treatment that also leads
to longest survival is surgical resection. However, due to poor performance status, locally …
to longest survival is surgical resection. However, due to poor performance status, locally …
Pancreatic Cancer
K Mann, A Sheel, P Ghaneh - Treatment of Cancer, 2020 - taylorfrancis.com
Obesity has been shown by many studies to increase the risk of pancreatic cancer. The
staging process of pancreatic cancer is through the tumor node metastasis classification of …
staging process of pancreatic cancer is through the tumor node metastasis classification of …